Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reversal of neuromuscular blockade by sugammadex during propofol-remifentanil anaesthesia
2009-009605-25Phase 4Completed
- Sponsor
- Hanna Illman
- Start
- Feb 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Sugammadex, sponsored by Hanna Illman. Primary endpoints: Change in bispectral index (BIS) values after sugammadex reversal and Change in entropy values after sugammadex reversal. Started Feb 2009; status: completed.
02
Drugs
Sugammadex
Beyond the preview
Go deeper on 2009-009605-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009605-25.